This is one of the projects De Bruin and Twist previously owned, and brought into AMED Funds.  AMED Funds provided the capital to SepFluor to complete the exploration work and Bankable Feasibility Study.  

Construction of the fluorspar mine plus concentrator (the first phase) was completed within budget ($120 million) and on time and commercial production commenced in 2019.Capacity: 180,000 tpa acidspar. 

The second phase comprises the construction of a chemical plant that will convert 160,000 tpa fluorspar concentrate into Hydrogen fluoride, Aluminium fluoride, Anhydrite and Metspar. The CAPEX of the second phase is about $330 million and the company is presently raising the capital to do this.

Grade: Nokeng: 27% CaF₂; Wallmannsthal: 46% CaF₂

Resource: Nokeng: 12.2 Mt; Wallmannsthal: 7.9 Mt

Stage of Development:

• Nokeng: In production
• Wallmannsthal: BFS in progress

AMED Funds shareholding: 68%